4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine
C29H20N16O — CID 141087437
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine
4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine (PubChem CID 141087437) has the molecular formula C29H20N16O and a molecular weight of 608.59 g/mol. Its IUPAC name is 4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine.
Molecular Properties
| Compound Name | 4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine |
|---|---|
| PubChem CID | 141087437 |
| Molecular Formula | C29H20N16O |
| Molecular Weight | 608.59 g/mol |
| Exact Mass | 608.20 |
| IUPAC Name | 4-[4-pyrazin-2-yl-3-(1H-pyrazol-5-yl)-3-pyridazin-3-yl-6-pyridin-2-yl-5-pyrimidin-2-yl-2-(2H-tetrazol-5-yl)-4H-pyran-2-yl]triazine |
| SMILES | c1ccc(C2=C(c3ncccn3)C(c3cnccn3)C(c3cccnn3)(c3ccn[nH]3)C(c3ccnnn3)(c3nn[nH]n3)O2)nc1 |
| InChI | InChI=1S/C29H20N16O/c1-2-9-31-18(5-1)25-23(26-33-10-4-11-34-26)24(19-17-30-15-16-32-19)28(21-7-13-36-39-21,20-6-3-12-35-38-20)29(46-25,27-41-44-45-42-27)22-8-14-37-43-40-22/h1-17,24H,(H,36,39)(H,41,42,44,45) |
| InChIKey | DJFLILVZZUMUDH-UHFFFAOYSA-N |
| XLogP | 1.49 |
| TPSA | 221.27 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 608.59 |
| LogP ≤ 5 | 1.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141087437 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.